drugset / Trial / NCT01097408

Pharmacokinetics of AZD7295 Capsules

NCT01097408 ↗

Phase 1 Completed 12 enrolled Arrow Therapeutics
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a pharmacokinetics (PK) and safety study of AZD7295 in healthy volunteers.

Timeline

Start
2010-03
Primary completion
2010-05
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD7295 Small molecule 650 mg —

Indications

No indication recorded.